| Literature DB >> 28255500 |
Iulia Gabriela David1, Dana-Elena Popa1, Mihaela Buleandra1.
Abstract
Due to their electrochemical and economical characteristics, pencil graphite electrodes (PGEs) gained in recent years a large applicability to the analysis of various types of inorganic and organic compounds from very different matrices. The electrode material of this type of working electrodes is constituted by the well-known and easy commercially available graphite pencil leads. Thus, PGEs are cheap and user-friendly and can be employed as disposable electrodes avoiding the time-consuming step of solid electrodes surface cleaning between measurements. When compared to other working electrodes PGEs present lower background currents, higher sensitivity, good reproducibility, and an adjustable electroactive surface area, permitting the analysis of low concentrations and small sample volumes without any deposition/preconcentration step. Therefore, this paper presents a detailed overview of the PGEs characteristics, designs and applications of bare, and electrochemically pretreated and chemically modified PGEs along with the corresponding performance characteristics like linear range and detection limit. Techniques used for bare or modified PGEs surface characterization are also reviewed.Entities:
Year: 2017 PMID: 28255500 PMCID: PMC5307002 DOI: 10.1155/2017/1905968
Source DB: PubMed Journal: J Anal Methods Chem ISSN: 2090-8873 Impact factor: 2.193
Electroanalytical applications of unmodified PGEs.
| Compound | Technique | Linear range ( | LD ( | Sample | Ref. |
|---|---|---|---|---|---|
| Acebutolol | DPV | 1–15 | 0.0126 | Urine | [ |
| Acetaminophen | CV; FI | 100–5000 | Pharmaceuticals | [ | |
| Acetylsalicylic acid | SWV | 35–300 | 167 | Pharmaceuticals | [ |
| Acyclovir | DPV | 1–100 | 0.3 | Pharmaceuticals | [ |
| Caffeic acid/TPC | FIA-Amp | 1–20 | Tea infusion | [ | |
| Caffeic acid/TPC | DPV | 0.1–3000 | 0.0883 | Tea infusion | [ |
| Caffeine | SWASV | <500 | 9.2 | Tea | [ |
| Chlorogenic acid | DPV | 0.1–500 | 0.0714 | Dietary supplements | [ |
| Dantrolene sodium | DPV | 0.395–2.955 | 0.09 | Pharmaceuticals, human mother milk, urine | [ |
| Eugenol | DPV | 0.3–50 | 0.085 | Pharmaceuticals | [ |
| Famotidine | DPV | 0.472–495 | 0.151 | Pharmaceuticals | [ |
| Flutamide | SWCASV | 0.398–6.36 | 0.0155 | Bulk form, human urine, serum | [ |
| Hydroxyurea | DPV | 10–1000 | 7.89 | Pharmaceuticals, human urine | [ |
| Itraconazole | SWASV | 10.6–127 | 8.7 | Pharmaceuticals, biological fluids | [ |
| Methylergometrine maleate | DPV | 0.10–1.00 | 0.02 | Pharmaceuticals | [ |
| Niclosamide | DPV | 0.05–10.0 | 0.015 | Pharmaceuticals | [ |
| Ozone | Amp | 30–400 | 0.6 | Tap water | [ |
| Paclitaxel | DPV | 0.4–3.0 | 0.00246 | Pharmaceuticals, biological fluids | [ |
| Rosmarinic acid | DPV | 0.01–10 | 0.00793 | Tea infusion | [ |
| Salicylic acid | SWV | 0.1-80 | 1.7 | Willow barks and branches | [ |
| Silver | DPV | 0.015–0.25 | 0.01 | Waters, tobacco cells, fish tissues | [ |
| Strontium ranelate | SWV | 1–10 | 0.17 | Pharmaceuticals | [ |
| Trepibutone | SWV | 0.24–10 | 20 | Pharmaceuticals | [ |
| Uranium | SWASV | <0.00008 | 0.000007 | Rocks, earthworm | [ |
| Vitamin B1 | DPV | 10.0–1000 | 5.34 | Pharmaceuticals | [ |
ng·mL−1; µg·mL−1; DPV: differential pulse voltammetry; SWV: square wave voltammetry; CV: cyclic voltammetry; FI(A): flow injection (analysis); Amp: amperometry; SWASV: square wave anodic stripping voltammetry; SWCASV: square wave cathodic adsorptive stripping voltammetry; TPC: total polyphenolic content.
Electroanalytical applications of ETPGEs.
| Compound | Technique | Linear range ( | LD ( | Sample | Ref. |
|---|---|---|---|---|---|
| Alkylphenols | DPV | Water | [ | ||
| 4-Nonylphenol | 1.20–94 | 0.420 | |||
| 4-Octylphenol | 0.6–78 | 0.250 | |||
| 4-tert-Octylphenol | 2.38–243 | 0.770 | |||
|
| |||||
| 4-Aminophenazone | DPV | 1–11 | 0.0796 | Real samples | [ |
|
| |||||
| Benzo(a)pyrene | SWSV | 0.25–1.25 | 0.027 | Spiked human urine | [ |
|
| |||||
| Bisphenol A | AdDPSV | 0.05–5; 5–10 | 0.0031 | Tape and river water | [ |
|
| |||||
| Boron | DPV | 280–12000 | 84 | Water, steel | [ |
|
| |||||
| Capsaicin, dihydrocapsaicin | AdSWSV | 0.016–0.32 | 0.0037 | Turkish pepper | [ |
|
| |||||
| Chlorpromazine | DPV | 0.35–35 | 0.2 | Human plasma, urine | [ |
|
| |||||
| Cinchocaine hydrochloride | DPV: ox | 1.5–18 | 0.664 | Spiked human urine | [ |
|
| |||||
| Dopamine | ATSDPV | 0.01–5.0 | 0.00031 | Blood serum | [ |
|
| |||||
| Dopamine | DPV | 0.15–15 | 0.033 | Pharmaceuticals, body fluids | [ |
|
| |||||
| Gluten | DPV | 20–100 | 7.11 | Flour, vinegar, baker's yeast | [ |
|
| |||||
| Indole-3-acetic acid | SWV | 0.5–2; 2.5–10 | 0.14 | Maize plant extracts | [ |
|
| |||||
| Methamphetamine | DPV | 0.074–54 | 0.05 | Human serum, urine | [ |
|
| |||||
| Morphine | DPV, Amp | 1–100 | 0.26 | Human urine, street drug samples | [ |
|
| |||||
| Nalbuphine hydrochloride | DPV | 16–150 | 6.38 | Spiked urine, pharmaceuticals | [ |
|
| |||||
|
| LSASV | 0.01–2.0 | 0.0015 | Water | [ |
|
| |||||
| Nicotine | SWV | 7.6–107.5 | 2.0 | Cigarettes | [ |
|
| |||||
| Paracetamol | ATSDPV | 0.05–2.5 | 0.0025 | Blood serum | [ |
|
| |||||
| Phenol | SWV | 0.05–1 | 0.00417 | Water | [ |
|
| |||||
| Phenol, m-cresol | DPV | 40–320 | 0.120 | Insulin formulations | [ |
|
| |||||
| Quercetin | DPASV | 0.001–1.5 | 0.0003 | Cranberry, blackcurrant juices | [ |
|
| |||||
| Tannic acid | DPASV | 0.005–0.5 | 0.0015 | Beverages | [ |
|
| |||||
| Uric acid | DPV | 0.05–10 | 0.0015 | Body fluids | [ |
|
| |||||
| Uric acid | DPV | 1–160 | 0.19 | Human serum, urine | [ |
|
| |||||
| Vitamin C | Amp | 1–100 | 1.18 | Human plasma | [ |
aIn solution: SDS (sodium dodecyl sulphate) < critical micellar concentration; ng·mL−1; µg·mL−1; SWSV: square wave stripping voltammetry; AdDPSV: adsorptive differential pulse stripping voltammetry; AdSWSV: adsorptive square wave stripping voltammetry; ox: oxidation; red: reduction; ATSDPV: adsorptive transfer stripping voltammetry differential pulse voltammetry; LSASV: linear sweep anodic stripping voltammetry; DPASV: differential pulse anodic striping voltammetry. All the other abbreviations are like those in Table 1.
Electroanalytical applications of modified PGE.
| Compound | Modifier | Technique | Linear range ( | LD ( | Sample | Ref. |
|---|---|---|---|---|---|---|
| Acetaminophen | Poly[2,5-di(2-hiophenyl) | DPV | 0.025–5 | 0.00194 | Pharmaceuticals | [ |
|
| ||||||
| Acyclovir | ET | SWAdSV | 0.05–0.6 | 0.00759 | Dosage forms, urine | [ |
|
| ||||||
| 2-Amino-benzimidazole | MI-PPy | DPV | 0.001–30000 | 0.0001 | Biological model samples | [ |
|
| ||||||
|
| MI-FUAA/MWCNTs-COOH | DPASV | 0.75–205.19 | 0.28 | Cerebrospinal fluid, human serum, aqueous | [ |
|
| ||||||
| Arsenic(V) | PPy-AsO43− | Pot | 50–100000 | 28 | Water | [ |
|
| ||||||
| Arsenic(III) | Au-NDs/CNTs | ASV | 0.5–80 | 0.4 | Tap water | [ |
|
| ||||||
| Ascorbic acid | MI-PPy | DPV | 250–7000 | 74 | Pharmaceuticals | [ |
|
| ||||||
| D-, L- | MI-PANI-FSA-C-dots | DPV | 0.006–0.155 | 0.000002 | Pharmaceuticals, human plasma | [ |
|
| ||||||
| D-, L- | MI-PI3AA/MWCNTs | DPASV | 0.15–7.4 | 0.025 | Pharmaceuticals, blood serum | [ |
|
| ||||||
| D-, L- | MI-NAPD/MWCNTs-TiO2-NPs-CHPA | DPASV | 9.98–516.25 | 1.71 | Cerebrospinal fluid, blood serum, pharmaceuticals | [ |
|
| ||||||
| Benzimidazole | MI-PPy | DPV | 3–5000 | 0.7 | Biological | [ |
|
| ||||||
| Bisphenol A | Au-NPs/PVP | SWAdSV | 0.03–1.1 | 0.001 | Bottled drinking water | [ |
|
| ||||||
| Bisphenol A | PANI-NRs/MWCNTs | Amp | 1–400 | 0.01 | Spiked boiling water | [ |
|
| ||||||
| Cadmium | P4VP | Pot | 0.1–100000 | 0.0251 | Environmental, food, biological | [ |
|
| ||||||
| Cadmium | Poly(4VP-co-Ani) | Pot | 1–10000 | 0.794 | Sea water, tomato, rice, ayurvedic medicine | [ |
|
| ||||||
| Caffeine | Au-NPs/MIP-sol-gel | SWV | 0.002–0.05 | 0.0009 | Urine, plasma, tablets, tea, energy and soda drink | [ |
|
| ||||||
| Carminic acid | Pd-Au-NPs/PPr | SWV | 0.01–1 | 0.0059 | Popping candy | [ |
|
| ||||||
| Ceftriaxone sodium | Copper hexacyanoferrate | CV, chrono-amp | 2–72 | 0.54 | Pharmaceuticals | [ |
|
| ||||||
| Ciprofloxacin | MI-PPy and o-PD | SWV | 0.001–1000 | 0.0000758 | Tablets | [ |
|
| ||||||
| Chlorogenic acid | MI-PPy | Pot | 1–10000 | 1 | Coffee | [ |
|
| ||||||
| Chlorpyrifos | MI-PPy | EIS | 20–300 | 4.5 | Soil | [ |
|
| ||||||
| Copper | Alga-OMNiIIP | DPASV | 0.008–7.807 | 0.0018 | Environmental, pharmaceuticals, blood serum | [ |
|
| ||||||
| Copper | Cu-carmoisine/PANI | Pot | 5–100000 | 2 | Tea leaves, black currants, sour cherry juice | [ |
|
| ||||||
| Copper | PPy-SSA | Pot | 10–100000 | 5.42 | Electrical copper wire | [ |
|
| ||||||
| Copper | PPy-P4R | Pot | 10–50000 | 6.7 | Electrical copper wire, tap water | [ |
|
| ||||||
| Copper | PSS–CnP | DPASV | <1000 | 0.00173 | Mineral, river and sea water | [ |
|
| ||||||
| L-Cysteine | Copper hexa-cyanoferrate NS | chrono-amp | 1–13 | 0.13 | Urine | [ |
|
| ||||||
| Dextromethorphan | Poly(diallyl-dimethyl-ammonium chloride)/MWCNT/CQDs | DPV | 2–600 | 0.2 | Cough syrups, human urine, plasma | [ |
|
| ||||||
| Diazepam | ET Bi | DPV | 1.4–16.7 | 1.1 | Tablets, urine | [ |
|
| ||||||
| Diclofenac sodium | MWCNTs | DPV | 0.047–12.95 | 0.017 | Biological samples, pharmaceuticals | [ |
|
| ||||||
| 1,4-Dihydroxy-anthraquinone | MI-PPy/MWCNTs-COOH | DPV | 0.01–100 | 0.00415 | Serum, plasma | [ |
|
| ||||||
| Dipyrone | PPy-dipyrone | Pot | 100–40000 | 86.2 | Spiked human urine, Pharmaceuticals | [ |
|
| ||||||
| Dopamine | Poly(xylenol orange) | DPV | 2–9 | 0.091 | Injections | [ |
|
| ||||||
| Dopamine | Poly(amaranth) | DPV | 0–250 | 0.05 | Injections | [ |
|
| ||||||
| Dopamine | Poly(Naphthol Green B) | DPV | — | — | Injections | [ |
|
| ||||||
| L-Dopa | Au | DPV | 20–100 | 1.54 |
| [ |
|
| ||||||
| Epinephrine | MI-poly(NHPM-MWCNTs) | DPASV | 0.09–5.90 | 0.02 | Pharmaceuticals, blood serum | [ |
|
| ||||||
| Estradiol | Au-NPs/MWCNTs | LSV | 0.07–42 | 0.01 | Blood serum | [ |
|
| ||||||
| Ferritin | Imprinted Ag@CdS | DPV | 1.99–23.43 | 0.65 | Blood serum | [ |
|
| ||||||
| Fluoxetine | PVC/PEDOT-C14 | ITSV | 0.1–1.0 | 0.035 | Tap and river water | [ |
| Citalopram | 0.025 | |||||
| Sertraline | 0.045 | |||||
|
| ||||||
| Folic acid | MI-pTAT/sol-gel | DPCSV | 0.007–0.156 | 0.0021 | Blood serum, pharmaceuticals | [ |
|
| ||||||
| Glucose | OxPPyNFs-CoPcTS | DPV | 250–20000 | 100 | Serum samples | [ |
|
| ||||||
| Glucose | Cu-NPs | Amp | 1–100 | 0.44 | Blood serum | [ |
|
| ||||||
| Glyphosate | MI-pMAC/AuNPs | DPASV | 3.98–176.23 | 0.35 | Aqueous, soil, | [ |
| Glufosinate | 0.54–3.96 | 0.19 | ||||
|
| ||||||
| Heavy metals | Bi-film | SWASV | 0.01–0.12 | Pb: 0.0024 | Simultaneous in situ, aqueous solutions | [ |
|
| ||||||
| Heavy metals | Nafion-graphene nanocomposite-Bi-film | SWASV | 2–20 | Pb: 0.13 | Tap water | [ |
|
| ||||||
| Heavy metals | ERGO-Bi-film | SWASV | 2–100 | Pb: 0.12 | Tap water | [ |
|
| ||||||
| Hemoglobin | MI-pNMGA/QDs-MWCNTs | DPCSV | 27.8–444.0 | 6.73 | Blood | [ |
|
| ||||||
| L-Histidine | CIP/MWCNTs | DPASV | 9.990–323.572 | 1.980 | Pharmaceuticals, blood serum | [ |
|
| ||||||
| Hydrazine | Au-NPs | SWV | 0.05–1000 | 0.042 | Drinking water | [ |
|
| ||||||
| Hydrazine | Cu-NS/MWCNT | SWV | 0.1–800 | 0.07 | River, waste, well waters | [ |
|
| ||||||
| Hydrochlorothiazide | MI-PPy/MWCNTs-COOH | DPV | 0.0009–10 | 0.0001 | Pharmaceuticals, serum | [ |
|
| ||||||
| Hydrogen peroxide | Ag/FeOOH nanocomposites | Amp | 30–15000 | 22.8 | Disinfectant | [ |
|
| ||||||
| Hydrogen peroxide | Pd-NPs | Amp | 10–140 | 0.045 | — | [ |
|
| ||||||
| Hydrogen peroxide | Pt-NPs | Amp | 10–110 | 3.6 | — | [ |
|
| ||||||
| Insulin | MI-pAEP-MWCNTs | DPASV | 0.000058–0.005647 | 0.0000186 | Pharmaceuticals, blood serum | [ |
|
| ||||||
| Iodide | PPy-iodide | Pot | 10–100000 | 9.3 | Pharmaceuticals | [ |
|
| ||||||
| K+, Na+ | PB | CV | 1000–500000 | 600–12000 | Synthetic | [ |
|
| ||||||
| Lorazepam | MI-PPy/sol-gel/AuNPs | SWV | 0.0002–0.002 | 0.00009 | Pharmaceuticals, plasma, urine | [ |
|
| ||||||
| Lomustine | MF | SWCASV | 0.192–13.6 | 0.0813 | Human blood, urine | [ |
|
| ||||||
| Magnesium | PPy-Titan yellow | Pot | 10–50000 | 6.28 | Tap and mineral water | [ |
|
| ||||||
| Mancozeb | SPIONs/MISP | — | 5.96–257.0 | 0.96 | Soil, vegetable | [ |
|
| ||||||
| Methadone | MWCNTs | DPV | 0.1–15 | 0.087 | Human serum, urine | [ |
|
| ||||||
| D-, L- Methionine | MI-polyBz/MWCNTs-COOH | DPV | 11.7–188.7 | 3 | Pharmaceuticals, blood serum | [ |
|
| ||||||
| Metoprolol | MI-PPy/MWCNTs-COOH | DPV | 0.06–490 | 0.00288 | Pharmaceuticals, serum | [ |
|
| ||||||
| Morphine | Au-NPs/MIP/MWCNT | SWV | 0.008–5 | 0.0029 | Human urine, serum | [ |
|
| ||||||
| Nitrate | PPy-NO3− | Pot | 100–100000 | 50 | Water | [ |
|
| ||||||
| Nitrite | Polypyronin Y | Amp | 1–100 | 0.5 | Food | [ |
|
| ||||||
| Nitrite | PVF+/MWCNTs | DPV | 1–400 | 0.1 | Mineral water | [ |
|
| ||||||
| 4-Nitrophenol | MWCNTs | FI-Amp | 5–300 | 1.5 | Water | [ |
|
| ||||||
| 4-Nitrophenol | Cu | Amp | 50–850 | 1.91 | [ | |
|
| ||||||
| 2-Nitrophenol | Bi | DPV | 2–200 | 5.42 | [ | |
|
| ||||||
| Pantoprazole | PPy-PTZ | Pot | 10–11000 | 6.9 | Pharmaceuticals | [ |
|
| ||||||
| Paracetamol | MI-PPy | DPV | 5–500 | 0.79 | Pharmaceuticals | [ |
|
| ||||||
| Phenothiazine | MI-PPy | DPV | 1–300 | 0.3 | Model and real biological | [ |
|
| ||||||
| D-, L- Pyroglutamic acid | MI-poly[5-MTCA–Cu(II)] | DPASV | 2.8–170.0 | 0.77 | Cerebrospinal fluid, blood plasma, urine | [ |
|
| ||||||
| Quercetin | p-AMT | DPV | 0.1–6 | 2.2 | — | [ |
|
| ||||||
| Ranitidine | Au-NP/MIP-sol–gel/MWCNTs-COOH | SWV | 0.05–2.0 | 0.02 | Human urine | [ |
|
| ||||||
| Serotonin | p(P3CA) | AdDPSV | 0.01–1.0 | 0.0025 | Blood serum, urine | [ |
|
| ||||||
| Sildenafil citrate | PPy-citrate | Pot | 34–1700 | 30 | Pharmaceuticals | [ |
|
| ||||||
| Sulfanilamide | MI-PPy | DPV | 0.05–1.1 | 0.02 | Spiked human serum, ground water | [ |
|
| ||||||
| Sulfamethoxazole | MI-OxPPy | DPV | 25–750 | 0.359 | Pharmaceuticals | [ |
|
| ||||||
| Thiocarbohydrazide | MI-PPy | DPV | 500–6000 | 50 | Biological | [ |
|
| ||||||
| 6-Thioguanine | MI-polyneutral red/ERGO | DPASV | 0.124–78.0 | 0.02 | Pharmaceuticals, urine, serum | [ |
|
| ||||||
| Triamterene | MI-PPy/MWCNTs-COOH | DPV | 0.08–265 | 0.00335 | Serum, pharmaceuticals | [ |
|
| ||||||
| L-Tyrosine | graphene | SWV | 0.8–60 | 0.07 | Urine | [ |
|
| ||||||
| Uranium(VI) | PPy-ZnUO2(CH3COO)4 | Pot | 1–10000 | 0.63 | Mineral and tap water | [ |
|
| ||||||
| Uric acid | Ox-PEDOT-nf | DPV | 0.01–20.0 | 0.0013 | Blood serum, urine | [ |
|
| ||||||
| Valacyclovir | CuMPs | AdSWV | 0.002–0.01 | 0.000178 | Pharmaceuticals | [ |
|
| ||||||
| Vitamin B12 | PNT | SWV | 0.2–9.5 | 0.093 | Tablets | [ |
|
| ||||||
| Vitamin B12 | SWCNTs-chitosan | SWV | 0.005–0.1 | 0.00089 | Pharmaceuticals | [ |
|
| ||||||
| Zinc | Tartrazine-PPy | Pot | 10–100000 | 8 | Barley flakes, rice dry milk | [ |
ng·mL−1; µg·mL−1; ET: electrochemically treated; MI: molecularly imprinted; PPy: polypyrrole; FUAA: 5-fluorouracil-N-acetyl acrylamide; NDs: nanodendrites; CNT: carbon nanotubes; ASV: anodic stripping voltammetry; FSA: ferrocene sulfonic acid; PI3AA: poly(indole-3-acetic acid); NAPD: N-acryloyl-pyrrolidine-2,5-dione; NPs: nanoparticles; CHPA: 2-chloro-N-(4-hydroxyphenyl)-acetamide; PVP: polyvinylpyrrolidone; SWAdSV: square wave adsorptive stripping voltammetry; PANI: polyaniline; NRs: nanorodes; MWCNTs: multiwall carbon nanotubes; P4VP: poly(4-vinyl pyridine); poly(4VP-co-Ani): poly(4-vinylpyridine-co-aniline); MIP: molecularly imprinted polymer; PPr: polyproline; chronoamp: chronoamperometry; o-PD: o-phenylenediamine; EIS: electrochemical impedance spectroscopy; OMNiIIP: one monomer ion imprinted polymer; SSA: sulfosalicylic acid; P4R: Ponceau 4R azo dye; PSS-CnP: polystyrene sulfonate-carbon nanopowders; NS: nanostructure; CQDs: carbon quantum dots; NHPM: N-hydroxyphenyl maleimide; LSV: linear sweep voltammetry; Ag@CdSNPs: AgCdS core shell nanoparticles; PVC: poly(vinyl chloride); PEDOT-C14: 3,4-ethylenedioxythiophene; ITSV: ion transfer stripping voltammetry; pTAT: poly(triaminotriazine); DPCSV: differential pulse cathodic stripping voltammetry; OxPPy: overoxidized polypyrrole; NFs-nanofibers; CoPcTS: cobalt(II) phthalocyanine tetrasulfonate; pMAC: poly(N-methacryloyl-L-cysteine); ERGO: electrochemically reduced graphene oxide; pNMGA: poly(N-methacryloyl glutamic acid); QD: quantum dots; CIP: complex imprinted polymer; pAEP: poly[(p-acryloylaminophenyl)-{(4-aminophenyl)-diethyl ammonium}-ethylphosphate]; PB: Prussian Blue; MF: mercury film; SPIONs: superparamagnetic iron oxide nanoparticles; MISP: molecularly imprinted star polymer; Bz: benzidine; PVF: poly(vinylferrocene); PTZ: pantoprazole; MTCA: methyl-2-thiophene carboxylic acid; p-AMT: polymerized 5-amino-2-mercapto-1,3,4-thiadiazole; p(P3CA): poly(pyrrole-3-carboxylic acid); Ox-PEDOT-nf: overoxidized poly (3,4-ethylene-dioxythiophene) nanofibers; CuMPs: copper micropoarticles; PNTs: peptide nanotubes; copper microparticles; SWCNTs: single-wall carbon nanotubes. All the other abbreviations are like those in the previous tables.
PGE used in tandem with separation techniques.
| Compound | PGE modifier | Technique | Linear range ( | LD ( | Sample | Ref. |
|---|---|---|---|---|---|---|
| D-, L- Aspartic acid | MIP | MIP-SPME-DPASV | 0.6–10 | 0.180 | Blood serum, cerebrospinal fluid | [ |
|
| ||||||
| Buprenorphine | MWCNTs | PTFE-LPME- | 0.000001–0.000109 | 0.0000006 | Human urine and plasma | [ |
|
| ||||||
| Clozapine | — | EME-DPV | 3–1500 | 0.9 | Human plasma | [ |
|
| ||||||
| Epinephrine | MIP/MWCNTs-NHPM | MI-MSPE-DPASV | 0.005–8 | 0.002 | Cerebrospinal fluid, plasma, pharmaceutics | [ |
|
| ||||||
| Flutamide | SDS-modified | DPV | 0.0001–0.1 | 0.000034 | Human urine and plasma | [ |
|
| ||||||
| Insulin | RuO2-GO nanocomposite | DPV | 0.0008–0.02 | 0.000024 | Blood, urine | [ |
|
| ||||||
| D-, L- Methionine | EC-MIP/MWCNTs-COOH | MI-MSPE- | 0.03–30.00 | 0.0098 | Pharmaceuticals, human blood plasma | [ |
|
| ||||||
| Tramadol | RGO | EM-SPME- | 0.01–0.50 | 0.003 | Urine | [ |
ng mL−1; µg mL−1; MI(P): molecularly imprinted (polymer); SPME: solid phase microextraction; PTFE: polytetrafluorethylene; LPME: liquid three-phase microextraction; EM(E): electromembrane (extraction); MI-MSPE: MI-micro-solid-phase extraction; SDS: sodium dodecyl sulphate; (R)GO; (reduced) graphene oxide; EC-MIP: electrochemically synthesized-MIP. All the other abbreviations are like those in the previous tables.